Barclays’s Black Diamond Therapeutics BDTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $74K | Sell |
29,870
-36,774
| -55% | -$91.1K | ﹤0.01% | 3886 |
|
|
2025
Q1 | $103K | Sell |
66,644
-19,901
| -23% | -$30.8K | ﹤0.01% | 3675 |
|
|
2024
Q4 | $186K | Buy |
86,545
+8,394
| +11% | +$18K | ﹤0.01% | 3555 |
|
|
2024
Q3 | $339K | Buy |
78,151
+52,265
| +202% | +$227K | ﹤0.01% | 3211 |
|
|
2024
Q2 | $121K | Sell |
25,886
-141,360
| -85% | -$661K | ﹤0.01% | 3285 |
|
|
2024
Q1 | $848K | Hold |
167,246
| – | – | ﹤0.01% | 2517 |
|
|
2023
Q4 | $470K | Sell |
167,246
-155,000
| -48% | -$436K | ﹤0.01% | 3034 |
|
|
2023
Q3 | $925K | Buy |
322,246
+197,895
| +159% | +$568K | ﹤0.01% | 2141 |
|
|
2023
Q2 | $628K | Buy |
124,351
+105,000
| +543% | +$530K | ﹤0.01% | 2454 |
|
|
2023
Q1 | $37K | Hold |
19,351
| – | – | ﹤0.01% | 3854 |
|
|
2022
Q4 | $35K | Sell |
19,351
-1,584
| -8% | -$2.87K | ﹤0.01% | 3885 |
|
|
2022
Q3 | $35K | Sell |
20,935
-1,057
| -5% | -$1.77K | ﹤0.01% | 3754 |
|
|
2022
Q2 | $54K | Sell |
21,992
-4,388
| -17% | -$10.8K | ﹤0.01% | 3699 |
|
|
2022
Q1 | $73K | Buy |
+26,380
| New | +$73K | ﹤0.01% | 3817 |
|